MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2026 International Congress

    The association of low back pain-related disability with functional mobility among individuals with Parkinson disease in Sri Lanka.

    YS. Thakshila, HHN. Kalyani (Colombo, Sri Lanka)

    Objective: This study aimed to examine the association between low back pain (LBP) related disability and functional mobility in individuals with Parkinson disease (PD). Background:…
  • 2026 International Congress

    Heterogeneous Responsiveness to Combined Motor–Cognitive Exercise in Parkinson’s Disease: A Latent Class Analysis

    J. Hwang, C. Youm, H. Park, M. Kim, B. Kim, S. Cheon (busan, Republic of Korea)

    Objective: To evaluate the effects of a combined motor–cognitive exercise intervention in individuals with Parkinson’s disease (PD) and to explore latent response subgroups to identify…
  • 2026 International Congress

    Specific thalamic subnuclei volumes associate with autonomic dysfunction in Parkinson’s disease

    S. Haji, W. Sako, K. Takabayashi, K. Kamagata, T. Hatano, N. Hattori (Bunkyo-ku, Japan)

    Objective: To elucidate the association between autonomic symptoms and Parkinson’s disease (PD) subgroups stratified by k-means clustering of thalamic subnuclear volumes measured by MRI. Background:…
  • 2026 International Congress

    White Matter Hyperintensity and the Spatial Subtypes in Parkinson’s Disease

    XY. Xie, HL. Wang, YL. Du, G. Wang (Shanghai, China)

    Objective: To determine whether white matter hyperintensity (WMH) volume and its spatial subtypes, periventricular WMH (PWMH) and deep WMH (DWMH), are associated with cognitive impairment…
  • 2026 International Congress

    Genetic analysis of the X chromosome and Parkinson’s disease

    N. Kuznetsov, M. Makarious, K. Levine, D. Vitale, C. Blauwendraat, A. Singleton, H. Leonard (Washington, USA)

    Objective: To investigate chromosome X genetic risk factors for Parkinson’s disease (PD) across European and Ashkenazi Jewish ancestries and establish a robust framework for X-chromosome…
  • 2026 International Congress

    The Association between Antiepileptic Drug Use, Epilepsy and the Risk of Parkinson’s Disease: A Systematic Review and Meta-analysis

    RG. Mohamed, O. Yousef (Mansoura, Egypt)

    Objective: To assess the relationship between epilepsy, antiepileptic drug use, and Parkinson's disease Background: Parkinson's disease (PD) is a progressive neurodegenerative disorder with multiple risk…
  • 2026 International Congress

    Neuromelanin Loss Is Associated with Increased Substantia Nigra Free-Water: a Longitudinal Study of Controls, RBD, and PD

    V. Madge, K. Wennberg, R. Klevor, A. Dagher, R. Postuma, D L. Collins (Montréal, Canada)

    Objective: To longitudinally characterize substantia nigra (SN) neuromelanin (NM) and free-water (FW) MRI biomarkers by comparing control, REM sleep behaviour disorder (RBD), and Parkinson’s disease…
  • 2026 International Congress

    Reasons and Factors Influencing Parkinson’s Patients’ Decision to Decline Deep Brain Stimulation

    L. Cabrera, H. King, L. Al Damluji, J. Blumenthal-Barby, B. Levi, S. de Jesus (University Park, USA)

    Objective: To investigate reasons and factors influencing Parkinson’s patients’ decision to decline deep brain stimulation (DBS). Background: While much research has focused on patients with…
  • 2026 International Congress

    Cerebral Small Vessel Disease-Related Degeneration of Cholinergic Pathways Contributes to Cognitive Impairment in Parkinson’s Disease

    SM. Rong, XL. Cui, R. Yang, ZH. Li, YH. Zhang, MF. Cai (Guangzhou, Guangdong Province, China)

    Objective: To determine whether cerebral small vessel disease (SVD) metrics contributes to cognitive impairment in Parkinson’s disease (PD) through microstructural damage to cholinergic projection pathways.…
  • 2026 International Congress

    Genetic analysis of Mongolian patients with Parkinson’s Disease

    B. Tserensodnom, KH. Tulgaa (Ulaanbaatar, Mongolia)

    Objective: To investigate the distribution of genetic variants among Mongolian patients with Parkinson’s disease  within the framework of the international GP2 project MONPAR study .…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley